Skip to main content
. Author manuscript; available in PMC: 2015 Jan 1.
Published in final edited form as: Am J Addict. 2013 Jun 10;23(1):34–40. doi: 10.1111/j.1521-0391.2013.12052.x

Figure 1.

Figure 1

Effect of HCV serostatus on the pharmacokinetics of (a) buprenorphine, (b) norbuprenorphine, (c) buprenorphine-3-glucuronide, and (d) norbuprenorphine-3-glucuronide.